Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases
Advanced Functional Materials · 2023-08 · 33 (31)
DOI: 10.1002/adfm.202211846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 28.04.2023. Verfasst von Jingwen Deng und 12 weiteren Autor:innen. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The development of colitis‐associated colorectal cancer is known to be associated with the inflammation‐dysplasia‐carcinoma pathway, and thus, chronic inflammation represents an inducer and promoter of cancer. To inhibit the evolution from colitis to colorectal cancer and provide an efficient anticancer therapy, a surface‐engineered vanadium carbide MXene nanoenzyme (MXenzyme) is developed with both amino functionalization and gallium doping (Ga/V 2 C‐NH 2 ). Benefiting from multiple enzyme‐mimicking activities, MXenzymes have shown great potential to decrease excessive reactive oxygen species and inhibit the levels of proinflammatory cytokines, resulting in good anti‐inflammatory effects on dextran sulfate sodium‐induced acute colitis. Moreover, the gallium‐doped MXene with an amino‐functionalized surface can mediate improved MXene‐tumor interactions and inhibitory effects on cell proliferation, achieving precise and efficient chemo‐photothermal therapy. Elemental doping into MXene is also highlighted as a feasible strategy to achieve the loading and controlled release of gallium. As a result, complete tumor ablation without further recurrence is observed for the colon cancer‐bearing mice that receive Ga/V 2 C‐NH 2 and near infrared irradiation, while the MXenzyme system displays excellent biocompatibility at both the cellular and animal levels. These findings not only enrich the research of MXene, but also illustrate its efficient therapeutic promise in anti‐inflammation and photoenhanced antitumor therapy of colon diseases.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, J., Xian, D., Cai, X., Liao, S., Lei, S., Han, F., An, Y., He, Q., Quan, G., Wu, C., Peng, T., Lu, C., & Zhang, H. (2023). Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases. Advanced Functional Materials, 33(31). https://doi.org/10.1002/adfm.202211846
Vancouver
Deng J, Xian D, Cai X, Liao S, Lei S, Han F, et al. Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases. Advanced Functional Materials. 2023;33(31). doi:10.1002/adfm.202211846
BibTeX
@article{Deng2023,
author = {Deng, Jingwen and Xian, Dongyi and Cai, Xiaopeng and Liao, Shaoxia and Lei, Siqin and Han, Fengyan and An, Yandong and He, Qing and Quan, Guilan and Wu, Chuanbin and Peng, Tingting and Lu, Chao and Zhang, Honghe},
title = {Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases},
journal = {Advanced Functional Materials},
year = {2023},
volume = {33},
number = {31},
doi = {10.1002/adfm.202211846}
}
EUVIMED